| Trial ID: | L1109 |
| Source ID: | NCT02671162
|
| Associated Drug: |
Wheat
|
| Title: |
Evaluating the Effect of Fumaria Parviflora L. in Uremic Pruritus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End-Stage Renal Disease|Pruritus
|
| Interventions: |
DRUG: Wheat|DRUG: Fumaria
|
| Outcome Measures: |
Primary: Severity of Pruritis as measured by a visual analogue scale (VAS), A '0' score represented absence of pruritus and a '10' represented the greatest severity of symptoms., 3 months | Secondary: Serum Interferon-gamma level, 4 months|Serum IL-4 level, 4 months|Serum high-sensitive C reactive protein (hs-CRP), 4 months
|
| Sponsor/Collaborators: |
Sponsor: Shiraz University of Medical Sciences
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
63
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2015-07
|
| Completion Date: |
2016-01
|
| Results First Posted: |
|
| Last Update Posted: |
2016-02-02
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT02671162
|
